Safety evaluation of biosimilar trastuzumab in breast cancer: Experience of Colombian institutions

11/10/2022
23/04/2024
EU PAS number:
EUPAS49290
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A6181236_Protocolo Biosimilares_V1_07Oct2022_ENG

English (1011.19 KB - PDF) View document
Updated protocol

A6181236_PROTOCOL V2.0_15Feb2023_ENG_Final

First published: 22/02/2024
English (1.29 MB - PDF) View document
Study results
Study report
Other information